Ocular Oncology

All malignancies involving the eye, eyelid, orbit, and tear, or lacrimal, glands are managed by ocular oncology, or eye cancer, services. Some of them are benign, while others are cancerous and aggressive. The most effective approaches to prevent and treat eye cancers are investigated in ocular oncology research. On the eyelid, orbit, cornea, conjunctiva, iris, retina, or optic nerve, eye tumours can develop as a primary or metastatic tumour. Ocular oncology research, often known as eye cancer research, focuses on the best ways to prevent and treat eye cancer. Novel diagnostic tests, surgical treatments, radiation therapy, and chemotherapy, as well as targeted genetic therapies including the creation of new anti-angiogenic drugs, are all possibilities.

•    Advance Patient care
•    Challenges
•    Adverse events
•    Disorders
•    Diagnosis and Treatment

Market Analysis:
The global Ocular Drug Delivery market size is estimated to be worth USD26590 million in 2022 and is forecast to a readjusted size of USD35220 million by 2028 with a CAGR of 4.8% during the review period.